
Temperature excursions cost pharma an estimated $35 billion a year as biologics, GLP-1s and cell and gene therapies raise cold chain stakes.
about 8 years ago
Gimme my dataabout 8 years ago
A Conversation with Rafik Bisharaabout 8 years ago
The 2018 Pharma Cold Chain: more data leads to less riskabout 8 years ago
Biopharma cold-chain market forecast
